Does SUMATRIPTAN Cause Pulmonary embolism? 10 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Pulmonary embolism have been filed in association with SUMATRIPTAN (sumatriptan succinate). This represents 0.1% of all adverse event reports for SUMATRIPTAN.
10
Reports of Pulmonary embolism with SUMATRIPTAN
0.1%
of all SUMATRIPTAN reports
2
Deaths
7
Hospitalizations
How Dangerous Is Pulmonary embolism From SUMATRIPTAN?
Of the 10 reports, 2 (20.0%) resulted in death, 7 (70.0%) required hospitalization.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for SUMATRIPTAN.
What Other Side Effects Does SUMATRIPTAN Cause?
Drug ineffective (2,941)
Product physical issue (2,349)
Application site erythema (1,875)
Drug dose omission (1,711)
Product quality issue (1,269)
Application site pain (1,217)
Migraine (978)
Headache (914)
Product complaint (718)
Nausea (702)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which SUMATRIPTAN Alternatives Have Lower Pulmonary embolism Risk?
SUMATRIPTAN vs SUMATRIPTAN\SUMATRIPTAN
SUMATRIPTAN vs SUMAVEL DOSEPRO
SUMATRIPTAN vs SUNITINIB
SUMATRIPTAN vs SUNITINIB MALATE
SUMATRIPTAN vs SUTENT